Studies have shown that neoadjuvant nivolumab may provide long-term benefits for people with non-small cell lung cancer.

Published Date: 17 Feb 2023

BACKGROUND: NSCLC is the most common and important cause of cancer worldwide. Assessment: The patient...

Read Full News

Latest News


News All Time

Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

Extended lymphadenectomy has no survival benefit in patients with muscle-invasive bladder cancer.

2.

Did U.S. Government Play a Role in Remote Tribe's Widespread Illness and Cancer?

3.

New CAR-T Drug Induces Durable Remissions in ALL, Published Data Show

4.

Preoperative MRI is useful for identifying additional disease in breast cancer patients with nodes positive.

5.

Key mechanism behind prostate cancer drug resistance reveals potential new treatment strategy


© Copyright 2026 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
bot